International Stem Cell (ISCO) Net Shares Issued and Repurchased (2013 - 2025)

International Stem Cell (ISCO) has reported Net Shares Issued and Repurchased for 13 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 43.89% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 43.89% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 43.89% from the prior year.
• Net Shares Issued and Repurchased was $1.1 million for Q4 2025 at International Stem Cell, up from $734.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $10.0 million in Q3 2023 and troughed at $668.0 in Q1 2022.
• A 5-year average of $2.6 million and a median of $1.4 million in 2021 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased surged 111.69% in 2023 and sank 84.2% in 2024, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2021, then soared by 32.72% to $2.3 million in 2022, then soared by 111.69% to $5.0 million in 2023, then slumped by 84.2% to $782222.0 in 2024, then soared by 43.89% to $1.1 million in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $1.1 million (Q4 2025), $734.0 (Q1 2025), and $782222.0 (Q4 2024), per Business Quant data.